This Day That Year: 10x Genomics Inc. (TXG)

(RTTNews) - Shares of 10x Genomics Inc. (TXG), which closed at an all-time high of $125 on Friday, have gained 64 percent so far this year.

It was on this day last year, i.e. on September 12, 2019, that the company made its debut on the Nasdaq Global Select Market by setting a public offering at $39 per share.

10x Genomics is a life science technology company developing single-cell solution and spatial gene expression lab hardware and software for analyzing biological systems. The single-cell solutions run on the Chromium instruments and the spatial gene expression solution is based on the Visium platform.

While single-cell analysis gives researchers the ability to see what is inside a cell, the Visium platform for spatial molecular profiling lets researchers see how cells are organized in relation to one another, allowing for a deeper understanding of biological systems in both normal and disease states.

The company's customers primarily include academic, government, biopharmaceutical, biotechnology, and other institutions, spread across over 40 countries. Since launching its first product in mid-2015 through December 31, 2019, 10x Genomics is said to have sold 1,666 instruments to researchers around the world, including 97 of the top 100 global research institutions and 19 of the top 20 global biopharmaceutical companies.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Октябрь 2020    »